Hence, the present study offers further insight into the molecular mechanisms underlying NSCLC pathology and highlights the effectiveness of PERK inhibition against NSCLC cells in normal and ER stress conditions. Here, EIF2AK3 is linked to non-small cell lung carcinoma.